Voya Financial, Inc.’s (VOYA - Free Report) first-quarter 2019 net operating income of $1.07 per share missed the Zacks Consensus Estimate by 5.3% due to lower revenues. However, the bottom line improved 23% year over year.
The company’s revenues of $1.4 billion decreased 20% from the year-ago quarter.
Assets under management and administration were $547 billion as of Mar 31, 2019.
Retirement’s adjusted operating earnings of $129 million increased 18.3% year over year on the back ofpositive DAC/VOBA and other intangibles, lower fee-based margin owing to low average asset balances, etc.
Investment Management posted adjusted operating earnings of $34 million and generated $1.1 billion of Institutional net flows, reflecting strong commercial growth in the business and the 13th straight quarter of positive institutional net flows.
Employee Benefits’ adjusted operating earnings were $38 million, up 19% year over year on the back of an improved loss ratio for Stop Loss and a rise in the Voluntary block.
Individual Life’s adjusted operating earnings were $48 million, up 182.4%year over year.
Corporate incurred adjusted operating losses of $55 million, narrower than the year-ago quarterly losses of $56 million owing to a decrease in the standard costs on account of its sale of substantially all its individual annuities businesses.
Voya Financial exited the first quarter with $705 million in excess capital.
In the quarter under review, the company completed its $250-million accelerated share repurchase deal and entered into a new $236-million accelerated share repurchase agreement.
Its board of directors also announced $500 million worth of an additional share buyback, which expires on Jun 30, 2020.
The company is intended to hike its common stock dividend to a minimum yield of 1% in the beginning of third-quarter 2019.
Zacks Rank and Performance of Other Peers
Voya Financial has a Zacks Rank #2 (Buy).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players from the insurance industry having posted first-quarter earnings so far, the bottom-line results of The Travelers Companies, Inc. (TRV - Free Report) , Cincinnati Financial Corporation (CINF - Free Report) and The Progressive Corporation (PGR - Free Report) surpassed the respective Zacks Consensus Estimate.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>